TY - JOUR
T1 - Heparin attenuated neutrophil infiltration but did not affect renal injury induced by ischemia reperfusion
AU - Shin, Cheung Soo
AU - Han, Jeong Uk
AU - Kim, Jung Lyul
AU - Schenarts, Paul J.
AU - Traber, Lillian D.
AU - Hawkins, Hal
AU - Traber, Daniel L.
PY - 1997
Y1 - 1997
N2 - Although heparin is better known as an anticoagulant, it also has several anti-inflammatory effects. Heparin is known to inhibit neutrophil adhesion, chemotaxis and oxygen free radical production. In addition, heparin is also known to act as an oxygen radical scavenger. Our hypothesis was that heparin would attenuate renal ischemia reperfusion injury. In this study, we investigated whether heparin had a protective effect on renal ischemia reperfusion injury. Sheep (n=12) were prepared for the chronic study with venous, arterial and urinary catheters inserted. In addition, pneumatic occluders and ultrasonic flow probes were placed on renal arteries. After a 5-day recovery period, the sheep were randomized to either a heparin treatment group (400 IU/kg IV bolus 10 minutes before renal artery occlusion, followed by a continuous effusion 25,000 IU in 250 ml of 0.9% NaCl at 10 ml/hr, n=6) or a control group (n=6), which received an equivalent volume of 0.9% NaCl. All the sheep then underwent 90 minutes of bilateral renal ischemia followed by 24 hours of reperfusion. Blood urea nitrogen (BUN), serum creatinine (Scr), and creatinine clearance (CrCl) were determined at various intervals during both the ischemic and reperfusion periods. Kidney tissue samples were obtained at autopsy for histologic examination. As a result, there were significant differences in the degree of inflammation (1.50±1.24 Vs 0.50±0.79, P<O. 05) between the control and heparin treatment groups, but not in the degree of injury (2.83±0.44 Vs 2.33±0.28). In this study, heparin significantly attenuated polymorphonuclear leukocytes (PMNs) infiltration within the interstitium, but it did not affect the degree of renal damage as measured by urinary chemistries or renal tubular damage as assessed by histopathologic evaluation.
AB - Although heparin is better known as an anticoagulant, it also has several anti-inflammatory effects. Heparin is known to inhibit neutrophil adhesion, chemotaxis and oxygen free radical production. In addition, heparin is also known to act as an oxygen radical scavenger. Our hypothesis was that heparin would attenuate renal ischemia reperfusion injury. In this study, we investigated whether heparin had a protective effect on renal ischemia reperfusion injury. Sheep (n=12) were prepared for the chronic study with venous, arterial and urinary catheters inserted. In addition, pneumatic occluders and ultrasonic flow probes were placed on renal arteries. After a 5-day recovery period, the sheep were randomized to either a heparin treatment group (400 IU/kg IV bolus 10 minutes before renal artery occlusion, followed by a continuous effusion 25,000 IU in 250 ml of 0.9% NaCl at 10 ml/hr, n=6) or a control group (n=6), which received an equivalent volume of 0.9% NaCl. All the sheep then underwent 90 minutes of bilateral renal ischemia followed by 24 hours of reperfusion. Blood urea nitrogen (BUN), serum creatinine (Scr), and creatinine clearance (CrCl) were determined at various intervals during both the ischemic and reperfusion periods. Kidney tissue samples were obtained at autopsy for histologic examination. As a result, there were significant differences in the degree of inflammation (1.50±1.24 Vs 0.50±0.79, P<O. 05) between the control and heparin treatment groups, but not in the degree of injury (2.83±0.44 Vs 2.33±0.28). In this study, heparin significantly attenuated polymorphonuclear leukocytes (PMNs) infiltration within the interstitium, but it did not affect the degree of renal damage as measured by urinary chemistries or renal tubular damage as assessed by histopathologic evaluation.
KW - Antiinflammatory effect
KW - Heparin
KW - Isehemia reperfusion injury
KW - Kidney
UR - http://www.scopus.com/inward/record.url?scp=8544267182&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=8544267182&partnerID=8YFLogxK
U2 - 10.3349/ymj.1997.38.3.133
DO - 10.3349/ymj.1997.38.3.133
M3 - Article
C2 - 9259612
AN - SCOPUS:8544267182
SN - 0513-5796
VL - 38
SP - 133
EP - 141
JO - Yonsei Medical Journal
JF - Yonsei Medical Journal
IS - 3
ER -